Volition issues business review 2024

Henderson, nev. , jan. 8, 2025 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition" or the "company"), a multi-national epigenetics company, has issued a business review of 2024, outlining its key highlights from the past year.

VNRX Ratings Summary

VNRX Quant Ranking